05/19/2026 05:00
TREASoURcE Shows How Circular Economy Solutions Can Move Beyond Pilots Across Sectors and Regions

Across Europe, many circular economy solutions struggle to move beyond isolated pilots and into real-world deployment at scale. New approaches are needed that combine technical feasibility, market relevance and citizen engagement, while remaining adaptable to local contexts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518914041/en/TREASoURcE addressed circular economy challenges across energy, plastics and biobased side stream...

05/19/2026 06:00
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics (“ATB” or the “Company”), a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, today announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho...

04/30/2026 11:00
Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint® and BluePrint® at the 2026 ESMO Breast Cancer Annual Congress

Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster...

04/30/2026 11:00
CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership

CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) m...

AFP Photographers Honoured at the 2024 POY Awards

Several AFP photographers have been honoured at the 82nd edition of the 2024 Pictures of the Year International (POY) awards, the world's oldest photojournalism competition, earning awards and special mentions across various categories.

Several AFP photographers have been honoured at the 82nd edition of the 2024 Pictures of the Year International (POY) awards, the world's oldest photojournalism competition, earning awards and special mentions across various categories.
04/14/2026 13:30
Andersen Global Launches Andersen in Pakistan

Andersen Global continues its regional growth in South Asia with the addition of Andersen in Pakistan as the latest member firm to join the global organization. Following its transition to the Andersen brand, the firm — formerly Saafin Global Consulting — brings a multidisciplinary practice serving clients across industries including manufacturing, energy, financial services, telecommunications, healthcare, real estate, and private equity. Headquartered in Islamabad, Andersen in Pakistan deli...